QA: Intelgenx Technologies Corp in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001098880_2019_Intelgenx_Technologies_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001098880, Intelgenx Technologies Corp

  xvar xval
0 AssetsCurrent 13,063,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,248,000
3 remainder_Assets 707,000
4 LiabilitiesCurrent 2,722,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 7,309,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,262,599
9 ResearchAndDevelopmentExpense 6,410,386
10 remainder_Expenses 845,514
11 remainder_Revenues 870,456
12 remainder_NetIncome 9,587
13 remainder_ComprehensiveNetIncome -124,635
  yvar yval
0 Assets 20,018,000
1 Liabilities 10,031,000
2 Expenses 12,518,499
3 Revenues 870,456
4 StockholdersEquity 9,987,000
5 NetIncome -11,638,456
6 ComprehensiveNetIncome -11,700,774
7 BaseVar 21,786,088
8 EconomicCapitalRatiobeforeLimitedLiability 0.670
9 EconomicCapitalRatio 2.03

Edgar->Model Mapping

Feature Distribution

Change over Time